- Home
- ISTR vs AARD Comparison
ISTR vs AARD Comparison
Compare ISTR & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- AARD
- Stock Information
- Founded
- ISTR 2006
- AARD 2017
- Country
- ISTR United States
- AARD United States
- Employees
- ISTR N/A
- AARD N/A
- Industry
- ISTR Major Banks
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- AARD Health Care
- Exchange
- ISTR Nasdaq
- AARD Nasdaq
- Market Cap
- ISTR 225.1M
- AARD 231.9M
- IPO Year
- ISTR 2014
- AARD 2025
- Fundamental
- Price
- ISTR $23.84
- AARD $10.57
- Analyst Decision
- ISTR Buy
- AARD Strong Buy
- Analyst Count
- ISTR 1
- AARD 8
- Target Price
- ISTR $29.00
- AARD $30.75
- AVG Volume (30 Days)
- ISTR 43.7K
- AARD 169.3K
- Earning Date
- ISTR 10-20-2025
- AARD 11-13-2025
- Dividend Yield
- ISTR 1.84%
- AARD N/A
- EPS Growth
- ISTR 24.14
- AARD N/A
- EPS
- ISTR 2.22
- AARD N/A
- Revenue
- ISTR $93,426,000.00
- AARD N/A
- Revenue This Year
- ISTR $7.24
- AARD N/A
- Revenue Next Year
- ISTR $70.19
- AARD N/A
- P/E Ratio
- ISTR $10.76
- AARD N/A
- Revenue Growth
- ISTR 12.93
- AARD N/A
- 52 Week Low
- ISTR $15.39
- AARD $4.88
- 52 Week High
- ISTR $25.71
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- ISTR 58.06
- AARD 44.14
- Support Level
- ISTR $23.62
- AARD $9.34
- Resistance Level
- ISTR $24.25
- AARD $11.51
- Average True Range (ATR)
- ISTR 0.59
- AARD 0.84
- MACD
- ISTR 0.00
- AARD 0.01
- Stochastic Oscillator
- ISTR 41.84
- AARD 48.94
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.